Ultragenyx received a Complete Response Letter from the FDA for UX111 AAV gene therapy to treat Sanfilippo Syndrome Type A ...

Solid Biosciences' DMD gene therapy shows promise with SGT-003 and strong cash backing through 2027. Click here to read an ...

Ultragenyx (RARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

TECH teams up with USP to boost mAb and gene therapy testing, aiming to simplify analytics and enhance product quality.

The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR ...

NHL free-agent market opened at noon ET on Tuesday. However, several teams avoided the rush by re-signing their pending ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $7.7, a high estimate of $11.00, ...

AHL Free Agency 2025 has officially begun. As all 32 teams look to fill out their rosters make sure you refresh this page daily for updates. Make sure you bookmark The Hockey News' AHL Page for the ...